Showing results (881-890 of 895) with videos related to

Sort By:
Pageof 90
Drugs in R&D|February 12, 2024
Pharmacokinetic and Safety Study of Bismuth Potassium Citrate Formulations in Healthy SubjectsHong-Yu Luo, Shuo-Guo Xu, Li-Chen Gao, et al.
Drugs in R&D|March 13, 2024
Effect of Daridorexant on the Pharmacokinetics of Midazolam, and on the Pharmacokinetics and Pharmacodynamics of Warfarin in Healthy Male SubjectsIsabelle Zenklusen, Jasper Dingemanse, Christian Reh, et al.
Drugs in R&D|July 23, 2024
Pharmacokinetic Bioequivalence and Safety Assessment of Two Venlafaxine Hydrochloride Extended-Release Capsules in Healthy Chinese Subjects Under Fed Conditions: A Randomized, Open-Label, Single-Dose, Crossover StudyYingxia He, Jie Wang, Fang Yao, et al.
Drugs in R&D|July 4, 2024
Exploring the Relationship Between Atorvastatin and Memory Loss: A Comprehensive Analysis Integrating Real-World Pharmacovigilance and Mendelian RandomizationKaiqin Chen, Yongtai Chen, Hesen Huang
Drugs in R&D|July 3, 2024
Demonstration of Physicochemical and Functional Similarity of Biosimilar Pegfilgrastim-cbqv to PegfilgrastimHenriette Kuehne, Janice M Davis, LeeAnne Merewether, et al.
Drugs in R&D|August 23, 2024
Effect of Chronic Dolutegravir Administration on the Trace Amine Profile in Wistar RatsNatasha Henning, Tracy A Kellermann, Carine Smith
Drugs in R&D|September 12, 2024
Changes in Early-Phase Clinical Trials in China During 2013-2022: A ReviewJianxiong Zhang, Peng Zhang, Haixue Wang, et al.
Drugs in R&D|August 20, 2024
Damoctocog Alfa Pegol, a PEGylated B-domain Deleted Recombinant Extended Half-life Factor VIII for the Treatment of Hemophilia A: A Product ReviewMark T Reding, Shadan Lalezari, Gili Kenet, et al.
Drugs in R&D|May 28, 2025
Network Meta-Analysis of Pharmacological Therapies for Long-Term Prophylactic Treatment of Patients with Hereditary AngioedemaSarah Walsh, Meaghan Bartlett, Elizabeth M Salvo-Halloran, et al.
Drugs in R&D|May 23, 2025
Evaluation of Anti-SARS-CoV-2 IgG Responses in a Clinical Study of a Biosimilar Candidate to Denosumab Using Singlicate AnalysisSandra Ribes, Natalia Krivtsova, Celine Schelcher, et al.
Pageof 90